HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sharon S Evans Selected Research

3,3'-diheptyloxycarbocyanine

9/2007Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sharon S Evans Research Topics

Disease

19Neoplasms (Cancer)
11/2019 - 12/2005
13Fever (Fevers)
06/2015 - 10/2003
5Hyperthermia
10/2013 - 01/2004
4Inflammation (Inflammations)
01/2018 - 07/2007
2Breast Neoplasms (Breast Cancer)
01/2018 - 06/2013
1Obesity
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2015
1Carcinogenesis
02/2014
1Infections
10/2013
1Neoplasm Metastasis (Metastasis)
08/2013
1Triple Negative Breast Neoplasms
06/2013
1Peritoneal Diseases
08/2011
1Hypoxia (Hypoxemia)
06/2011
1Communicable Diseases (Infectious Diseases)
12/2007

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
01/2018 - 01/2005
7Interleukin-6 (Interleukin 6)IBA
06/2015 - 01/2004
4L-SelectinIBA
12/2016 - 10/2003
4ElementsIBA
06/2015 - 12/2007
3salicylhydroxamic acid (SHAM)IBA
11/2019 - 08/2011
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2019 - 02/2009
2InterleukinsIBA
01/2018 - 06/2013
2Estrogen ReceptorsIBA
01/2018 - 06/2013
2ChemokinesIBA
05/2016 - 10/2013
2AntigensIBA
01/2015 - 03/2010
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
10/2011 - 01/2004
2Cell Adhesion MoleculesIBA
02/2009 - 12/2006
2Biological ProductsIBA
02/2008 - 07/2007
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2018
1AmberIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1TNF Receptor-Associated Factor 1IBA
01/2018
1Chemokine ReceptorsIBA
05/2016
1Interleukin-17 (Interleukin 17)IBA
10/2013
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2013
1Neoplasm Antigens (Tumor Antigens)IBA
10/2013
1InterferonsIBA
06/2013
1Phenobarbital (Luminal)FDA Link
06/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2013
1Interleukin-5 (Interleukin 5)IBA
06/2013
1Proteins (Proteins, Gene)FDA Link
10/2011
1P-SelectinIBA
10/2011
1SolutionsIBA
08/2011
1Saline SolutionIBA
08/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2007
13,3'-diheptyloxycarbocyanineIBA
09/2007
1Fluorescent Dyes (Fluorescent Probes)IBA
09/2007
1Coloring Agents (Dyes)IBA
09/2007
1Pharmaceutical PreparationsIBA
09/2007
1liposomal doxorubicin (Doxil)FDA Link
09/2007
1Chemokine CCL21IBA
12/2006
1Therapeutic UsesIBA
01/2004
1Hormones (Hormone)IBA
10/2003
1SteroidsIBA
10/2003

Therapy/Procedure

8Immunotherapy
11/2019 - 12/2005
4Therapeutics
10/2011 - 01/2004
3Radiofrequency Ablation
11/2019 - 01/2015
1Neoadjuvant Therapy
01/2015
1Photochemotherapy (Photodynamic Therapy)
10/2013
1Laparotomy
08/2011
1Lasers (Laser)
06/2011
1Radiotherapy
06/2011
1Induced Hyperthermia (Thermotherapy)
06/2009
1Intravenous Injections
09/2007